BSE Live
Jan 23, 16:01Prev. Close
458.10
Open Price
458.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 23, 15:48Prev. Close
458.00
Open Price
460.75
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
440.25 (137)
| Balance Sheet of Thyrocare Technologies (in Rs. Cr.) | Mar 15 | |
| 12 mths | ||
| EQUITIES AND LIABILITIES | ||
| SHAREHOLDER'S FUNDS | ||
| Equity Share Capital | 50.54 | |
| Total Share Capital | 50.54 | |
| Reserves and Surplus | 225.84 | |
| Total Reserves and Surplus | 225.84 | |
| Total Shareholders Funds | 276.37 | |
| Minority Interest | 36.01 | |
| NON-CURRENT LIABILITIES | ||
| Long Term Borrowings | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | |
| Other Long Term Liabilities | 6.38 | |
| Long Term Provisions | 3.16 | |
| Total Non-Current Liabilities | 9.54 | |
| CURRENT LIABILITIES | ||
| Short Term Borrowings | 0.00 | |
| Trade Payables | 0.84 | |
| Other Current Liabilities | 4.82 | |
| Short Term Provisions | 1.65 | |
| Total Current Liabilities | 7.30 | |
| Total Capital And Liabilities | 329.22 | |
| ASSETS | ||
| NON-CURRENT ASSETS | ||
| Tangible Assets | 149.59 | |
| Intangible Assets | 1.07 | |
| Capital Work-In-Progress | 5.04 | |
| Fixed Assets | 156.22 | |
| Non-Current Investments | 1.62 | |
| Deferred Tax Assets [Net] | 0.87 | |
| Long Term Loans And Advances | 14.50 | |
| Other Non-Current Assets | 0.00 | |
| Total Non-Current Assets | 218.55 | |
| CURRENT ASSETS | ||
| Current Investments | 84.30 | |
| Inventories | 7.37 | |
| Trade Receivables | 4.91 | |
| Cash And Cash Equivalents | 5.08 | |
| Short Term Loans And Advances | 7.53 | |
| OtherCurrentAssets | 1.49 | |
| Total Current Assets | 110.67 | |
| Total Assets | 329.22 | |
| OTHER ADDITIONAL INFORMATION | ||
| CONTINGENT LIABILITIES, COMMITMENTS | ||
| Contingent Liabilities | 441.19 | |
| BONUS DETAILS | ||
| Bonus Equity Share Capital | 37.38 | |
| NON-CURRENT INVESTMENTS | ||
| Non-Current Investments Quoted Market Value | 0.00 | |
| Non-Current Investments Unquoted Book Value | 1.62 | |
| CURRENT INVESTMENTS | ||
| Current Investments Quoted Market Value | 85.76 | |
| Current Investments Unquoted Book Value | 0.00 |
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
24.10.2025
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
28.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Consolidated September 2025 Net Sales at Rs 216.53 crore, up 22.09% Y-o-Y
15.10.2025
Thyrocare Techn Standalone September 2025 Net Sales at Rs 202.23 crore, up 24.03% Y-o-Y
24.07.2025
Thyrocare Techn Standalone June 2025 Net Sales at Rs 178.89 crore, up 24.55% Y-o-Y
06.10.2021
Thyrocare Technologies Q2 PAT may dip 2.9% YoY to Rs 41.8 cr: Prabhudas Lilladher
12.07.2019
Thyrocare Technologies Q1 PAT may dip 6.5% YoY to Rs. 22.1 cr: Prabhudas Lilladher
12.04.2019
Thyrocare Technologies Q4 PAT seen up 18.1% YoY to Rs. 29.7 cr: Prabhudas Lilladher
17.04.2018
Thyrocare Technologies Q4 PAT seen up 68.7% YoY to Rs 32 cr: Edelweiss